The article explores the potential of thioglycosides, sugar compounds with a sulfur substitution for oxygen, in disrupting bacterial glycan synthesis, specifically targeting pathogenic bacteria like Helicobacter pylori while sparing beneficial gut bacteria and human cell lines.